Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3020 |
|
| Actual shortage: | 234 (8%) | |
| Anticipated shortage: | 20 (1%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2757 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
28 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-INDAPAMIDE 1.25 MG TABLETS | 1.25MG | TABLET | Resolved | 2017-05-04 | 2017-12-14 | 8865 |
| APO-INDAPAMIDE 1.25 MG TABLETS | 1.25MG | TABLET | Resolved | 2017-07-17 | 2017-12-14 | 15973 |
| APO-INDAPAMIDE 1.25 MG TABLETS | 1.25MG | TABLET | Resolved | 2019-09-25 | 2020-03-02 | 94740 |
| APO-INDAPAMIDE 1.25 MG TABLETS | 1.25MG | TABLET | Resolved | 2021-02-05 | 2021-04-05 | 133379 |
| APO-INDAPAMIDE 1.25 MG TABLETS | 1.25MG | TABLET | Resolved | 2021-07-23 | 2021-08-31 | 142979 |
| APO-INDAPAMIDE 1.25 MG TABLETS | 1.25MG | TABLET | Resolved | 2023-05-12 | 2023-05-26 | 192370 |
| APO-INDAPAMIDE 1.25 MG TABLETS | 1.25MG | TABLET | Resolved | 2023-09-07 | 2023-11-24 | 203846 |
| APO-IMIQUIMOD | 5% | CREAM | Resolved | 2017-03-10 | 2019-11-26 | 333 |
| APO-IMATINIB | 400MG | TABLET | Resolved | 2017-07-31 | 2017-09-06 | 17609 |
| APO-IMATINIB | 400MG | TABLET | Resolved | 2017-11-28 | 2018-04-18 | 31010 |
| APO-IMATINIB | 400MG | TABLET | Resolved | 2018-07-31 | 2018-11-15 | 56986 |
| APO-IMATINIB | 400MG | TABLET | Resolved | 2018-11-30 | 2019-01-10 | 68221 |
| APO-IMATINIB | 400MG | TABLET | Resolved | 2019-03-13 | 2019-03-29 | 78512 |
| APO-IMATINIB | 100MG | TABLET | Resolved | 2021-01-29 | 2021-02-11 | 132718 |
| APO-IMATINIB | 400MG | TABLET | Resolved | 2021-04-16 | 2021-05-17 | 137578 |
| APO-IMATINIB | 400MG | TABLET | Resolved | 2021-06-25 | 2021-07-12 | 141532 |
| APO-IMATINIB | 400MG | TABLET | Resolved | 2022-02-18 | 2022-03-21 | 155314 |
| APO-IMATINIB | 100MG | TABLET | Resolved | 2022-04-08 | 2022-06-02 | 158358 |
| APO-IMATINIB | 400MG | TABLET | Resolved | 2022-04-08 | 2022-06-03 | 158361 |
| APO-IBUPROFEN TAB 600MG | 600MG | TABLET | Resolved | 2023-04-14 | 2023-04-21 | 189638 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60747 |
| APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64965 |
| APO-RILUZOLE | 50MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60744 |
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60735 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60738 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60741 | ||
| APO-RANITIDINE TABLET 300MG | 300MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60729 |
| APO-RANITIDINE TABLET 300MG | 300MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60732 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60723 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60726 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2019-01-02 | 2019-01-09 | 70810 |
| APO-RAMIPRIL | 1.25MG | CAPSULE | Discontinued | 2018-09-08 | 2019-03-29 | 60720 |
| APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-02-23 | 2019-09-12 | 40805 |
| APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-09-08 | 2018-10-05 | 60717 |
| APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71201 |
| APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71204 |
| APO-QUININE | 200MG | CAPSULE | Discontinued | 2018-09-08 | 2021-05-10 | 60711 |
| APO-QUININE | 300MG | CAPSULE | Discontinued | 2018-09-08 | 2021-05-10 | 60714 |
| APO-QUETIAPINE | 300MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60708 |
| APO-QUETIAPINE | 25MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 119950 |